Biomimetic Hydrogels with Immobilized EphrinA1 for Therapeutic Angiogenesis | Dr. Daniel Gould

Dr. Daniel Gould co-authored this research published in Biomacromolecules, examining a bioengineered hydrogel designed to promote angiogenesis, the formation of new blood vessels. This is confirmed as the correct Dr. Daniel J. Gould, with the publication appearing on his ORCID record from his bioengineering research period at Rice University and Baylor College of Medicine.

The development of functional blood vessels is a central challenge in tissue engineering and regenerative medicine. Without sufficient vascularization, engineered tissues can struggle to receive the oxygen and nutrients required for long-term survival and integration.

The researchers investigated a biomimetic polyethylene glycol, or PEG, hydrogel incorporating immobilized ephrinA1. EphrinA1 is involved in cellular signaling associated with vascular development, making it a potential tool for encouraging blood vessel formation within engineered materials.

By immobilizing ephrinA1 within the hydrogel, the researchers aimed to create a biological environment capable of providing localized and sustained signals to endothelial cells rather than relying solely on soluble growth factors.

The study evaluated how this engineered environment influenced endothelial cell behavior and vascular development. The findings demonstrated the potential for immobilized ephrinA1 to support angiogenic activity and help guide the formation of vascular structures within biomaterial systems.

This research contributes to the broader field of regenerative medicine by demonstrating how biomaterials can be engineered to actively interact with cells and reproduce biological signals involved in vascular development.